Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides

• Autors principals: Quanlan Fu (Autor), Yuandong Luo (Autor), Junjie Li (Autor), Pingping Zhang (Autor), Shuxian Tang (Autor), Xinyi Song (Autor), Jiawei Fu (Autor), Mengqi Liu (Autor), Rongmi Mo (Autor), Ming Wei (Autor), Hejie Li (Autor), Xiaosong Liu (Autor), Tianfang Wang (Autor), Guoying Ni (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Cancer remains a major global health challenge. Immunotherapy has revolutionized the management of cancer, yet only a limited number of patients respond to such treatments. This is largely attributed to the immunosuppressive tumor microenvironment, which diminishes the effectiveness of immunotherapy...